Churchill Management Has Trimmed Abbvie Com (ABBV) Position By $1.37 Million; Lakeland Bancorp (LBAI)’s Sentiment Is 1.45

Lakeland Bancorp, Inc. operates as the holding firm for Lakeland Bank that provides financial services and products for individuals and small to medium sized businesses. The company has market cap of $909.17 million. It offers commercial banking depository products, including savings, money market, and time accounts, as well as demand deposits; lending solutions, such as short and medium term loans, lines of credit, letters of credit, inventory and accounts receivable financing, real estate construction loans, mortgage loans, small business administration loans, commercial real estate loans, commercial and industrial loans, and equipment financing solutions, as well as merchant credit card services; and wire transfer, Internet banking, mobile banking, night depository, and cash management services. It has a 17.79 P/E ratio. The firm also provides consumer banking services, including checking accounts, savings accounts, NOW accounts, money market accounts, certificates of deposit, secured and unsecured loans, consumer installment loans, mortgage loans, and safe deposit services.

Churchill Management Corp decreased Abbvie Inc Com (ABBV) stake by 5.45% reported in 2017Q3 SEC filing. Churchill Management Corp sold 15,512 shares as Abbvie Inc Com (ABBV)’s stock rose 6.17%. The Churchill Management Corp holds 269,296 shares with $23.93M value, down from 284,808 last quarter. Abbvie Inc Com now has $159.56B valuation. The stock increased 1.56% or $1.54 during the last trading session, reaching $99.95. About 4.70 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 4, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. Cowen & Co downgraded AbbVie Inc. (NYSE:ABBV) on Monday, June 6 to “Market Perform” rating. The firm has “Buy” rating given on Tuesday, December 5 by Leerink Swann. Cowen & Co maintained AbbVie Inc. (NYSE:ABBV) on Friday, July 28 with “Hold” rating. Jefferies maintained the shares of ABBV in report on Monday, June 26 with “Buy” rating. The firm earned “Hold” rating on Monday, July 17 by Deutsche Bank. The rating was maintained by BMO Capital Markets with “Market Perform” on Thursday, November 16. The rating was maintained by Jefferies with “Buy” on Thursday, May 25. On Friday, March 10 the stock rating was maintained by Goldman Sachs with “Buy”. The firm has “Mkt Perform” rating given on Tuesday, October 18 by Leerink Swann. Morgan Stanley downgraded AbbVie Inc. (NYSE:ABBV) rating on Wednesday, June 8. Morgan Stanley has “Equal-Weight” rating and $65 target.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It fall, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Nichols And Pratt Advisers Limited Liability Partnership Ma stated it has 20,980 shares. Zevenbergen Capital Invests Llc owns 0.01% invested in AbbVie Inc. (NYSE:ABBV) for 3,262 shares. Van Hulzen Asset Mgmt Llc invested in 57,077 shares. Mayo Advisers Llc holds 7,508 shares. Raab & Moskowitz Asset Ltd Liability Co owns 0.45% invested in AbbVie Inc. (NYSE:ABBV) for 10,253 shares. Garrison Fincl Corporation reported 3.57% in AbbVie Inc. (NYSE:ABBV). Oakworth holds 11,771 shares. Zacks Mgmt reported 578,692 shares. Cypress Cap Group Inc has 2.82% invested in AbbVie Inc. (NYSE:ABBV). Plancorp Lc stated it has 0.48% in AbbVie Inc. (NYSE:ABBV). Monarch Cap Mgmt holds 2.31% or 69,750 shares. 15,454 were accumulated by Pictet Cie (Europe). Primecap Mngmt Ca has 0% invested in AbbVie Inc. (NYSE:ABBV). Mairs has invested 0.21% in AbbVie Inc. (NYSE:ABBV). Sns Gp Lc holds 1.48% or 65,042 shares in its portfolio.

Since July 31, 2017, it had 0 buys, and 8 selling transactions for $45.57 million activity. 87,899 shares were sold by GONZALEZ RICHARD A, worth $6.24 million on Thursday, August 3. 8,300 AbbVie Inc. (NYSE:ABBV) shares with value of $705,655 were sold by SALEKI-GERHARDT AZITA. Gosebruch Henry O sold $1.66M worth of stock or 18,300 shares. 145,510 shares were sold by Schumacher Laura J, worth $14.07 million. 6,699 shares valued at $589,512 were sold by Michael Robert A. on Thursday, September 28. $8.57M worth of stock was sold by RICHMOND TIMOTHY J. on Monday, December 18.

Churchill Management Corp increased Select Sector Spdr Tr Sbi Int (XLF) stake by 314,763 shares to 4.70M valued at $121.46 million in 2017Q3. It also upped Unitedhealth Group Inc Com (NYSE:UNH) stake by 1,590 shares and now owns 29,367 shares. Spdr Dow Jones Indl Avrg Etf U (DIA) was raised too.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28 billion for 17.47 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

The stock decreased 0.26% or $0.05 during the last trading session, reaching $19.2. About 82,898 shares traded. Lakeland Bancorp, Inc. (LBAI) has risen 69.96% since January 4, 2017 and is uptrending. It has outperformed by 53.26% the S&P500.

Mcrae Capital Management Inc holds 2.77% of its portfolio in Lakeland Bancorp, Inc. for 316,050 shares. Cardinal Capital Management Llc Ct owns 2.02 million shares or 1.7% of their US portfolio. Moreover, Banc Funds Co Llc has 1.37% invested in the company for 1.50 million shares. The New York-based Mendon Capital Advisors Corp has invested 0.85% in the stock. Systematic Financial Management Lp, a New Jersey-based fund reported 1.01 million shares.

Since January 1, 0001, it had 0 insider buys, and 3 selling transactions for $1.11 million activity.

Analysts await Lakeland Bancorp, Inc. (NASDAQ:LBAI) to report earnings on January, 25. They expect $0.29 EPS, up 11.54% or $0.03 from last year’s $0.26 per share. LBAI’s profit will be $13.73M for 16.55 P/E if the $0.29 EPS becomes a reality. After $0.29 actual EPS reported by Lakeland Bancorp, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.